Technical Analysis for WGS - GeneDx Holdings Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Calm After Storm | Range Contraction | -0.10% | |
Upper Bollinger Band Walk | Strength | -0.10% | |
Multiple of Ten Bearish | Other | -0.10% | |
Wide Bands | Range Expansion | -0.10% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 13 hours ago |
Up 5% | about 13 hours ago |
Up 3% | about 13 hours ago |
Up 2% | about 13 hours ago |
Down 2 % | about 14 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/20/2024
GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.
Sector: Healthcare
Industry: Health Information Services
Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 21.71 |
52 Week Low | 1.16 |
Average Volume | 393,221 |
200-Day Moving Average | 5.53 |
50-Day Moving Average | 11.02 |
20-Day Moving Average | 13.57 |
10-Day Moving Average | 16.85 |
Average True Range | 1.78 |
RSI (14) | 74.09 |
ADX | 43.83 |
+DI | 39.60 |
-DI | 8.05 |
Chandelier Exit (Long, 3 ATRs) | 16.38 |
Chandelier Exit (Short, 3 ATRs) | 14.10 |
Upper Bollinger Bands | 22.22 |
Lower Bollinger Band | 4.92 |
Percent B (%b) | 0.83 |
BandWidth | 127.54 |
MACD Line | 2.73 |
MACD Signal Line | 2.01 |
MACD Histogram | 0.7177 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 22.22 | ||||
Resistance 3 (R3) | 22.39 | 21.58 | 21.73 | ||
Resistance 2 (R2) | 21.58 | 20.83 | 21.49 | 21.57 | |
Resistance 1 (R1) | 20.43 | 20.36 | 21.00 | 20.25 | 21.40 |
Pivot Point | 19.61 | 19.61 | 19.90 | 19.53 | 19.61 |
Support 1 (S1) | 18.46 | 18.86 | 19.04 | 18.29 | 17.14 |
Support 2 (S2) | 17.64 | 18.40 | 17.56 | 16.97 | |
Support 3 (S3) | 16.49 | 17.64 | 16.81 | ||
Support 4 (S4) | 16.32 |